COMMITMENTS AND CONTINGENCIES (Details) $ in Millions |
9 Months Ended |
---|---|
Sep. 30, 2023
USD ($)
third_party
| |
Commitments And Contingencies [Line Items] | |
Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones | $ 788.3 |
Purchase commitment | 246.0 |
Purchase commitments expected to be paid in 2023 | 134.4 |
Early Stage Development Program | Third Party | |
Commitments And Contingencies [Line Items] | |
Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones | $ 591.5 |
Number of third parties | third_party | 2 |
Shareholder vs BioMarin Pharmaceutical Inc | |
Commitments And Contingencies [Line Items] | |
Loss contingency | $ 39.0 |